(Table 3).
Flexor tenosynovitis (Trigger Finger) is characterized by localized thickening, palpable nodule formation, and triggering during finger movements in the flexor tendon sheath.19 Yosipovitch et al. 19 found flexor tenosynovitis to be 5%. In our study, the frequency of flexor tenosynovitis was found to be 2.8%. In the literature, there are studies reporting a higher rate of flexor tenosynovitis. 2,6,11,19 Pandey et al. did not show a relationship between microvascular complications and flexor tenosynovitis, and Khader et al. associated retinopathy.9,13 In our study, there was no relationship between flexor tenosynovitis, neuropathy, and retinopathy, but a significant association was found with the presence of nephropathy (Table 3).
In patients with diabetes, Charcot arthropathy is a reduction in the normal afferent protective neural impulses, and therefore loss of protection from trauma to the joint leads to progressive, painless joint destruction.20 Charcot arthropathy is found to be in 0.1-5% of patients with diabetes. It is more common in type 2 diabetes and is equally common in men and women. The incidence increases with the duration of diabetes.21 In our study, Charcot arthropathy was found to be 1.7%. In a study published by Agrawal et al.8, the frequency of Charcot arthropathy was found to be 2.9%. In the study conducted by Stuck et al.22, the data of 652 patients with diabetes diagnosed with Charcot arthropathy were evaluated, and it was emphasized that the duration of diabetes was associated with Charcot arthropathy. In the same study, the incidence of Charcot arthropathy increased in patients with neuropathy and those with HbA1c levels above 7%. In our study, no relationship was found between metabolic parameters and microvascular complications in patients diagnosed with Charcot arthropathy.
The frequency of diabetic foot was found to be 6% in our study. In the study conducted by Ardic et al. 6, the frequency of diabetes foot was reported to be 6.4% and was associated with retinopathy. In a study evaluating 811 patients with type 2 diabetes by Kumar et al.,23 the prevalence of diabetic foot was found to be 5.3%. In our study, the diabetic foot was associated with age and duration of diabetes. A significant correlation was shown between the mean fasting blood glucose and proteinuria levels of the metabolic parameters and the diabetic foot. The relationship between all microvascular complications and diabetic foot was observed